LunaJoy Health vs Altria

Side-by-side comparison of AI visibility scores, market position, and capabilities

Altria leads in AI visibility (90 vs 20)

LunaJoy Health

EmergingHealthcare

General

AI-powered women's mental health telehealth for therapy and psychiatry with Medicaid focus; $6.6M YC-backed founded by psychiatrists using risk-scoring AI for maternal mental health at scale.

AI VisibilityBeta
Overall Score
D20
Category Rank
#1141 of 1167
AI Consensus
52%
Trend
stable
Per Platform
ChatGPT
28
Perplexity
11
Gemini
29

About

LunaJoy Health is an Atlanta-based AI-powered women's mental health platform providing therapy, psychiatric medication management, and coaching across all women's life stages — from adolescence through postpartum care and menopause — with particular focus on serving Medicaid populations who face the greatest barriers to mental healthcare access. Founded in 2022 by psychiatrists Sipra Laddha and Shama Rathi and backed by Y Combinator with $6.6 million raised, LunaJoy uses proprietary AI-driven risk scoring to predict patient deterioration and personalize treatment pathways at scale.

Full profile

Altria

LeaderConsumer Goods

Enterprise

Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.

AI VisibilityBeta
Overall Score
A90
Category Rank
#83 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
97
Gemini
99

About

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.

Full profile

AI Visibility Head-to-Head

20
Overall Score
90
#1141
Category Rank
#83
52
AI Consensus
58
stable
Trend
stable
28
ChatGPT
84
11
Perplexity
97
29
Gemini
99
22
Claude
86
15
Grok
87

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.